ORM-10103: a significant advance in sodium-calcium exchanger pharmacology?

C M Terracciano, J C Hancox

Research output: Contribution to journalArticle (Academic Journal)

3 Citations (Scopus)

Abstract

The sodium-calcium exchanger (NCX) is an electrogenic transporter that is widely expressed in different tissues. In the heart, the NCX plays important roles in calcium ion homeostasis, excitation-contraction coupling and the electrophysiological properties of cardiac myocytes. Precise determination of the roles of the NCX has somewhat been hampered by a lack of selective small molecule inhibitors. In this issue of the BJP, Jost and colleagues present data on a new NCX inhibitor, ORM-10103, which has submicromolar EC50 values against cardiac forward and reverse exchange activity. The compound exhibits improved selectivity over existing small molecule NCX inhibitors and, in particular, appears to be without effect on L-type calcium channels at high concentrations. ORM-10103 could therefore have significant value for studies of the (patho)physiological roles of the NCX in the heart. Further pharmacological studies are required to investigate the actions of ORM-10103 on cardiac cells and tissues and to determine its effects on non-cardiac NCX isoforms.

Original languageEnglish
Pages (from-to)765-7
Number of pages3
JournalBritish Journal of Pharmacology
Volume170
Issue number4
DOIs
Publication statusPublished - Oct 2013

Bibliographical note

© 2013 The British Pharmacological Society.

Keywords

  • Animals
  • Anti-Arrhythmia Agents
  • Benzopyrans
  • Female
  • Heart Ventricles
  • Male
  • Myocytes, Cardiac
  • Pyridines
  • Sodium-Calcium Exchanger

Fingerprint Dive into the research topics of 'ORM-10103: a significant advance in sodium-calcium exchanger pharmacology?'. Together they form a unique fingerprint.

  • Cite this